West Pharmaceutical Services EPS - Earnings per Share 2010-2024 | WST

West Pharmaceutical Services earnings per share (EPS) for the twelve months ending June 30, 2024 was $7.03, a 2.33% increase year-over-year.

  • West Pharmaceutical Services EPS for the quarter ending June 30, 2024 was $1.51, a 26.7% decline year-over-year.
  • West Pharmaceutical Services 2023 annual EPS was $7.88, a 1.94% increase from 2022.
  • West Pharmaceutical Services 2022 annual EPS was $7.73, a 10.84% decline from 2021.
  • West Pharmaceutical Services 2021 annual EPS was $8.67, a 89.72% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

West Pharmaceutical Services EPS - Earnings per Share 2010-2024 | WST

  • West Pharmaceutical Services EPS for the quarter ending June 30, 2024 was $1.51, a 26.7% decline year-over-year.
  • West Pharmaceutical Services 2023 annual EPS was $7.88, a 1.94% increase from 2022.
  • West Pharmaceutical Services 2022 annual EPS was $7.73, a 10.84% decline from 2021.
  • West Pharmaceutical Services 2021 annual EPS was $8.67, a 89.72% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M